Clinical Trial Update: Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes [NA]

View source ↗

Summary

A clinical trial is evaluating polyclonal anti-T-lymphocyte globulin (ATG) in individuals with Type 1 diabetes, but the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Polyclonal Anti-T-Lymphocyte Globulin (ATG) (anti-thymocyte globulin (ATG))

Snippet

Sponsor: Institute for Clinical and Experimental Medicine | Conditions: Diabetes Mellitus, Type 1 | NA | Status: UNKNOWN